Navigation Links
Amylin Pharmaceuticals Reports Fourth Quarter and Full Year 2011 Financial Results
Date:2/6/2012

uted

$ 0.09$ 0.13$ 0.09$  (0.15)Shares used in per share calculationsBasic

146,280144,033145,730143,525Diluted

146,778144,926146,274143,525(1) With the termination of the Lilly collaboration we have revised our non-GAAP presentation to exclude charges and credits relating to the reacquisition of the exenatide product rights, including amortization and interest expense relating to reacquired assets, and have added a new item to reflect an adjustment to GAAP operating loss for the payments we are required to make to Lilly for the promissory note related to the revenue sharing obligation, or 15% of net exenatide sales.AMYLIN PHARMACEUTICALS, INC.CONDENSED CONSOLIDATED BALANCE SHEETS(in thousands)December 31,December 31,20112010(unaudited)AssetsCash, cash equivalents and short-term investments

$204,065

$442,663Restricted cash

10,519

15,000Accounts receivable, net

45,489

54,645Inventories, net

111,959

118,629Other current assets

49,158

45,458Property and equipment, net

831,162

811,745Intangible and other assets related
to economic rights reacquired or to be reacquired

601,539

-Other assets

16,308

43,289Total assets

$1,870,199

$1,531,429Liabilities and stockholders' equity Current liabilities

296,017

401,595Other liabilities, net of current portion

292,584

317,654Promissory note related to revenue sharing
obligation, net of current portion

924,306

-Long-term debt

496,037

468,697Stockholders' (deficit)/equity

(138,745)

343,483Total liabilities and stockholders' (deficit)/equity

$1,870,199

$1,531,429
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity
2. Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society
3. Amylin and Lilly Announce Plans to Develop Pen Device for Exenatide Once Weekly
4. Amylin Pharmaceuticals Highlights New Data Supporting Therapeutic Potential of Obesity Pipeline at Obesity 2009
5. Amylin Pharmaceuticals Reports Third Quarter Financial Results
6. Amylin Pharmaceuticals and Eli Lilly and Company Statement on FDAs BYETTA(R) (Exenatide) Injection Update
7. Amylin Pharmaceuticals to Present at the 18th Annual Credit Suisse Healthcare Conference
8. Amylin Pharmaceuticals to Webcast Year-End Financial Results
9. Amylin Highlights 2010 Corporate Priorities at J.P. Morgan Healthcare Conference
10. Amylin and Takeda Announce Decision to Advance Development of Pramlintide/Metreleptin Combination Treatment for Obesity
11. Amylin Pharmaceuticals to Present at The Barclays Capital 2010 Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... Research and Markets( ... "Deciphering Global Major Pharmaceutical Companies, New Outsourcing ... It has been publicly recognized that ... a series of challenges in the recent years. ... overcapacities in small molecule product manufacturing; increasingly challenging ...
(Date:7/7/2015)... 2015  PAREXEL International Corporation (NASDAQ: PRXL ) will ... 2015 on Wednesday, August 5 th , 2015 after the ... on PAREXEL,s website at www.PAREXEL.com and on the ... host a conference call and live webcast at 10:00 a.m. ... the results.  To access the webcast, visit PAREXEL,s website at ...
(Date:7/7/2015)...   Bionik Laboratories Corp. (OTCBB: BNKL), ... core focus in robotic exoskeleton technology for users ... today that it has completed an additional sale ... its common stock and warrants for aggregate gross ... placement transaction.  This equity financing is the sixth ...
Breaking Medicine Technology:Deciphering Global Major Pharmaceutical Companies - New Outsourcing Demands and Strategies 2Deciphering Global Major Pharmaceutical Companies - New Outsourcing Demands and Strategies 3PAREXEL International Announces Date Of Fourth Quarter And Fiscal Year 2015 Earnings Release And Conference Call 2Bionik Laboratories Completes US$13.1 Million Private Placement 2Bionik Laboratories Completes US$13.1 Million Private Placement 3
... August 10, 2011 Agendia, a commercial-stage ... St. Gallen International Breast Cancer Conference (2011) Expert Panel,s ... patients by the particular biological subtype of their tumor ... According to the panel, "it is no longer tenable ...
... August 10, 2011 The report " ... Current Trends & Forecasts (2010   -   2015) ... administration, and applications; and studies the major market drivers, restraints, ... in North America (U.S. and Canada), Europe, Asia, Japan, ...
Cached Medicine Technology:International St. Gallen Expert Panel Highlights Importance of Molecular Subtyping in Breast Cancer Treatment 2International St. Gallen Expert Panel Highlights Importance of Molecular Subtyping in Breast Cancer Treatment 3MarketsandMarkets: "Radiopharmaceuticals for Therapy and PET/SPECT Imaging" Market to reach $4,734 Million by 2015 2MarketsandMarkets: "Radiopharmaceuticals for Therapy and PET/SPECT Imaging" Market to reach $4,734 Million by 2015 3
(Date:7/7/2015)... ... July 07, 2015 , ... Greatist today announced the ... helps active people find the most fun activities to do with friends. , The ... It also increases Greatist’s opportunity for events, e-commerce, and brand partnerships. , “I’ve been ...
(Date:7/7/2015)... Chicago, IL (PRWEB) , ... July 07, 2015 ... ... organized the only industry group whose board is limited to permit holders. The ... vision on how to move the industry forward and are committed to making ...
(Date:7/7/2015)... , ... July 07, 2015 , ... At the end of June Pacific Prime Renewals ... ‘go green’ . This initiative, spearheaded by the Renewals Manager, Danielle Cotton, aims to not ... , On this initiative Cotton explained, “We send anything between 300 and 600 pieces ...
(Date:7/7/2015)... ... July 07, 2015 , ... The Immune Deficiency ... its patient community using its IDF ePHR, an electronic personal health record powered ... (PI) to easily track their health information, including symptoms, diagnoses, medications, infusions and ...
(Date:7/7/2015)... ... ... Parents and guardians of teenagers or young adults will be interested in reading the ... and alcohol abuse located in Southwest Michigan. A recently released study by New York ... the “club drug” use among high school seniors. The blog post offers guidance to ...
Breaking Medicine News(10 mins):Health News:Greatist Acquires Active Lifestyle Brand Blood, Sweat & Cheers 2Health News:Cannabis Growers and Dispensaries Form Medical Cannabis Alliance of Illinois 2Health News:Pacific Prime Hong Kong Renewals Team Starts Push to go Green 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 3Health News:A Forever Recovery Releases New Information on “Club Drugs” and Tips for Parents of Teens and Young Adults 2
... PAUL, Minn., Jan. 29 U.S. President Barack ... on human embryonic stem cells (hESC) research and is ... the issue. On Aug. 9, 2001, the Bush administration ... those hESC lines derived before that date. Jonathan ...
... have complications, without ill effects, study finds , , THURSDAY, Jan. ... to babies still in the womb can reduce their post-birth ... growth the way multiple courses can, new research shows. , ... those given a second dose of steroids in utero had ...
... PRO Educational Initiative are AnnouncedPITTSBURGH, Jan. 29 ... electronic patient reported outcomes (ePRO) solutions and ... opened registration for ePROficiency(TM) 2009 -- its ... research professionals can visit http://www.invivodata.com/epro2009 ...
... American businesses take belt-,tightening to new levels to ... a new service to help organizations address one ... EquivaMeds ( www.EquivaMeds.com ) helps self-insured ... helps members analyze their,current medications, identify lower cost ...
... interventions developed by UCSF researchers have been selected ... and Prevention,s 2008 Compendium of Evidence-based HIV Prevention ... Video Doctor and the Healthy Living Projectcomprise two ... 57 rigorously evaluated highly effective HIV prevention programs ...
... BTA stat(R) Test Detects Bladder Tumor Associated Antigen in UrineCORTLANDT ... announce the direct availability of the BTA stat (R) ... (R) test is a point of care technology for the ... antibodies to detect the presence of bladder tumor associated antigen ...
Cached Medicine News:Health News:University of Minnesota's Internationally Recognized Stem Cell Experts Available for Interviews on What Lifting the Federal Funding Restrictions Will Mean to Stem Cell Research and to Patients Who Stand to Benefit 2Health News:Additional Steroid Dose May Help Preemies 2Health News:Additional Steroid Dose May Help Preemies 3Health News:invivodata Opens Registration for Annual Patient Reported Outcomes Conference 2Health News:invivodata Opens Registration for Annual Patient Reported Outcomes Conference 3Health News:CDC recognizes UCSF's research as critical to HIV prevention 2Health News:CDC recognizes UCSF's research as critical to HIV prevention 3Health News:Polymedco Introduces Point of Care Test for Recurrent Bladder Cancer Detection 2
50L...
... Hamilton is precision, ergonomics, and ... hand fatigue with soft non-slip, contoured ... with smooth, light plunger spring action ... and sterilization without the need for ...
... 2000 Pipette is a synonym for pipetting ... robust design, and superior operating comfort. Its ... the measuring stroke and blow-out as well ... system ensures utmost accuracy and precision. Ejection ...
250L...
Medicine Products: